Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
Pandemics and Biosecurity
21JUL

US bans entry from DRC, Uganda, S Sudan

3 min read
09:12UTC

On 18 May the United States imposed a 21-day entry ban on nationals of three African states, including green-card holders, three days before WHO formally advised against exactly such restrictions.

ScienceDeveloping
Key takeaway

The US entry ban runs against live WHO advice for the first time since the 2014 Ebola response.

On 18 May the United States imposed a 21-day entry ban on nationals of the Democratic Republic of Congo, Uganda and South Sudan, including green-card holders⁠1. US citizens may still enter but face enhanced public-health screening at George Bush Intercontinental Airport in Houston from 26 May⁠2. South Sudan was included despite having no confirmed Bundibugyo cases, on the stated logic of porous borders with the DRC⁠3. The measure followed three days after WHO declared the Bundibugyo emergency.

The ban came first; four days later WHO's Emergency Committee issued Temporary Recommendations advising against travel and trade restrictions, and the ban has not been lifted since⁠4. Africa CDC publicly opposed the restrictions on 19 May⁠5. A major power has now banned travel against live WHO advice during an active emergency for the first time since the West Africa Ebola crisis of 2014, whose travel-ban failures the IHR exit-screening model was written to replace.

Entry bans push exposed travellers toward unscreened land routes and onward third-country flights, the exact behaviour exit screening at source is built to capture, and they discourage the honest disclosure border co-operation depends on. Bans also operate on nationality rather than exposure: a green-card holder who has not left the US in a year falls under the bar, while the screening of returning US citizens at Houston targets actual travel history. The 21-day entry ban therefore catches people by passport, not by where they have been.

Washington's reach for a border measure rather than a deployment has a structural backdrop. The USAID outbreak-response unit that would have surged personnel to Ituri had already been disbanded before the emergency, leaving entry restriction as one of the few levers still readily available. For readers planning travel, the practical effect is narrow: the bar falls on green-card holders and nationals of the three countries, while US citizens face questions and a temperature check at Houston, not exclusion.

Deep Analysis

In plain English

On 18 May 2026, the United States banned entry for nationals of three countries: the Democratic Republic of Congo, Uganda, and South Sudan. The ban includes people with US permanent residency (green cards). South Sudan was included even though no Ebola cases had been confirmed there. Public-health experts consistently oppose travel bans during Ebola outbreaks because they do not stop the virus, they drive sick or worried people to use unofficial routes where they cannot be monitored. They also make healthcare workers from affected countries reluctant to volunteer to help, which is exactly the opposite of what a response needs. Four days after the ban was imposed, the WHO's own expert committee formally recommended against travel or trade restrictions.

Deep Analysis
Root Causes

The US entry ban tracks a structural gap left by the dismantling of USAID's outbreak-response unit: with no 90-person CDC field presence deployable to Ituri, the only publicly visible US action available is a border measure. Entry bans are administratively simple and politically legible; field surge deployment requires an institutional apparatus the current US government no longer has.

South Sudan's inclusion despite zero cases reflects the conflation of geographic proximity with epidemic risk. The Ituri-South Sudan border does carry genuine surveillance risk given ungated population movement, but including South Sudan in a travel ban without a confirmed case is epidemiologically unjustifiable and was designed to signal political decisiveness rather than epidemiological precision.

What could happen next?
  • Risk

    Travel bans that push affected-country nationals to use informal border crossings reduce the WHO's ability to conduct exit screening, the single most evidence-based border measure for Ebola.

  • Consequence

    Uganda and South Sudan nationals working abroad in healthcare roles may delay return to their countries of origin, reducing the human resource pool available for the Ituri response surge.

First Reported In

Update #4 · Ebola triples, response misfires

STAT News· 24 May 2026
Read original →
Causes and effects
This Event
US bans entry from DRC, Uganda, S Sudan
It is the first time since 2014 that a major power has banned travel against live WHO advice during an active emergency.
Different Perspectives
Pan American Health Organization
Pan American Health Organization
PAHO warned on 20 October that El Niño is set to intensify as the dengue season begins, and issued a regional screwworm alert on 16 October. It wants veterinary and human health workers reporting into one surveillance system.
UK Health Security Agency
UK Health Security Agency
UKHSA links three Salmonella Enteritidis clusters to imported eggs and has two large importers under investigation without naming either. Its sequencing led the Food Standards Agency to recall eggs from Kyiv producer Yasensvit.
ECDC
ECDC
ECDC says Europe's West Nile season affected a broader area than any before and calls Germany's first local Sindbis virus case not unexpected, since the virus was already found in German mosquitoes and birds. It cautions that missing clade data limit how far Europe's clade I mpox rise can be read.
Ghana Ministry of Health
Ghana Ministry of Health
Health Minister Kwabena Mintah Akandoh declared a yellow fever outbreak in the Upper West Region after a Dakar laboratory confirmed three cases, all of whom died. Ghana plans an emergency vaccination campaign in three districts this month.
Government of Côte d'Ivoire
Government of Côte d'Ivoire
Spokesperson Amadou Coulibaly reported 23 yellow fever cases and 11 deaths in Bounkani on 14 October and said the country holds more than 400,000 vaccine doses. He did not say how many cases were laboratory-confirmed, which leaves the outbreak's true size unclear.
World Health Organization
World Health Organization
WHO says no cause has been found for the Irkutsk technician's death and a laboratory-associated exposure cannot be fully excluded. Tedros Adhanom Ghebreyesus urged states to finish the pathogen-sharing annex that holds the Pandemic Agreement back from signature.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.